Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination

Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination

Blog Article

Vaccination is one of the cornerstones in the efforts towards ending the coronavirus disease 2019 (COVID-19) pandemic.However, several adverse effects of COVID-19 vaccination have been identified.Pityriasis rosea (PR)-like eruption is a rare cutaneous complication of immunization.

To the best of our knowledge, there have been no reports markbroyard.com of PR-like eruptions following inoculation with Oxford/AstraZeneca ChAdOx1 nCoV-19 (AZD1222) vaccine.Here, we described a case of PR-like eruption that developed 14 days after Oxford/AstraZeneca vaccination in a 52-year-old Thai woman with glioblastoma.Treatment with topical 0.

1% triamcinolone acetonide twice per day showed partial response after seven days.Despite this rare complication, our report highlights that the presence grandpas best of PR-like eruption is not a contraindication for subsequent vaccinations.